Literature DB >> 22903129

p,p'-Methoxyl-diphenyl diselenide prevents neurodegeneration and glial cell activation induced by streptozotocin in rats.

Simone Pinton1, Tuane Bazanella Sampaio, Rita M Ramalho, Cecília M P Rodrigues, Cristina Wayne Nogueira.   

Abstract

The purpose of this study was to investigate possible molecular targets involved in the neuroprotective effect of p,p'-methoxyl-diphenyl diselenide [(MeOPhSe)2], using a streptozotocin (STZ)-induced sporadic dementia of Alzheimer's type rat model. Male Wistar rats were injected with STZ (1.0 mg/8 μl; 4 μl/ventricle). After 21 days of STZ injection, regular diet-fed rats were supplemented with 10 ppm of (MeOPhSe)2 during 30 days. At the end of this period, rats performed object recognition and step-down passive avoidance tasks. Apoptosis was assessed by TUNEL staining and active caspase-3. Glial fibrillary acidic protein, ionized calcium binding adaptor molecule 1, and microtubule associated protein 2 were determined by immunofluorescence in rat hippocampus. The results demonstrate that the (MeOPhSe)2 dietary supplementation reversed STZ-induced memory impairment by enhancing memory in sham rats. (MeOPhSe)2 was also effective in reducing STZ-induced apoptosis and preserving dendrites and synapses. Moreover, (MeOPhSe)2 inhibited activation of microglia and astrogliosis induced by STZ in the rat hippocampus. We conclude that the (MeOPhSe)2 neuroprotective action is related to inhibition of apoptosis and suppression of inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22903129     DOI: 10.3233/JAD-2012-121150

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  3 in total

1.  Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.

Authors:  Mirna Ezzat Sorial; Nesrine Salah El Dine El Sayed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-10       Impact factor: 3.000

Review 2.  Toxicology and pharmacology of synthetic organoselenium compounds: an update.

Authors:  Cristina W Nogueira; Nilda V Barbosa; João B T Rocha
Journal:  Arch Toxicol       Date:  2021-04-01       Impact factor: 6.168

3.  Selenofuranoside Ameliorates Memory Loss in Alzheimer-Like Sporadic Dementia: AChE Activity, Oxidative Stress, and Inflammation Involvement.

Authors:  Cristiano Chiapinotto Spiazzi; Melina Bucco Soares; Aryele Pinto Izaguirry; Laura Musacchio Vargas; Mariane Magalhães Zanchi; Natasha Frasson Pavin; Ricardo Ferreira Affeldt; Diogo Seibert Lüdtke; Marina Prigol; Francielli Weber Santos
Journal:  Oxid Med Cell Longev       Date:  2015-05-21       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.